Comment: A modern dermatologist
In many ways it’s an exciting time to be practicing dermatology. First immunosuppressive medications, and now the biological revolution, have transformed, and continue to improve, our management of patients with inflammatory disease. In the biologics clinic this afternoon, patients, many of who have been ‘old friends’ for years (and for whom I had little new to offer to them for years), came along exhibiting almost normal skin. Nearly all these patients are enrolled in monitoring studies to document the safety and efficacy of their treatment. We chatted about how things have changed.
Dermatology in practice 2014; 20(3): 3–3
To continue reading this article, please sign in or register.